Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · June 03, 2023

Long-Term Safety of Methylphenidate in Children and Adolescents With ADHD

The Lancet Psychiatry


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Psychiatry
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
Lancet Psychiatry 2023 May 01;10(5)323-333, KKC Man, A Häge, T Banaschewski, SK Inglis, J Buitelaar, S Carucci, M Danckaerts, RW Dittmann, B Falissard, P Garas, C Hollis, K Konrad, H Kovshoff, E Liddle, S McCarthy, A Neubert, P Nagy, E Rosenthal, EJS Sonuga-Barke, A Zuddas, ICK Wong, D Coghill

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading